Loading…
Loading…
Structured register of government actions in the geoeconomic space — export controls, tariffs, sanctions, FDI screening, subsidies, industrial-policy laws — cross-referenced into the country, minerals, and ETF surface. Charter: docs/IPTM_CHARTER.md.
Severity 1-5 is the qualitative impact rating (1=minor, 5=structural). The bilateral-trade-grounded quant scorer is the next IPTM milestone. RBI (Register Breadth Index) is a complementary structural-breadth indicator from scripts/py/iptm/breadth.py; divergence between RBI and severity is itself informative (high-sev / low-RBI = strategic chokepoint; low-sev / high-RBI = broad but shallow). Every action has at least one primary source URL. Verify-or-don't-file. See also themes, timeline, graph, sankey, map, country exposure, sector exposure, material exposure (+ graph), weekly briefs, portfolio scan, escalation monitor, trans-shipment hubs. Internal triage tools (RSS-poller candidate feed, source-feed health) live under /admin/candidates + /admin/sources. Subscribe via Atom feed (accepts ?country=CN, ?material=lithium, ?issuer=BIS, ?type=export_control, ?etf=SOXX, ?company=NVDA, ?minSeverity=4, ?year=2026, ?q=…) or pull /api/iptm/actions.
BIS amends the Export Administration Regulations (EAR) to implement decisions reached at the Australia Group (AG) November 2021 and March 2022 Virtual Implementation Meetings and the July 2022 AG Plenary in Paris. The rule adds four marine toxins to ECCN 1C351.d (brevetoxins, gonyautoxins, nodularins, palytoxin), removes cholera toxin from the controlled list, updates plant pathogen nomenclature in 1C354 to reflect current taxonomy, and clarifies biological equipment definitions in ECCN 2B352 (medical isolator exclusions and the term "disinfected"). The changes align US controls with the current AG Common Control Lists without introducing new country-specific restrictions.
BIS amends the Export Administration Regulations (EAR) to implement the decision adopted at the Australia Group (AG) Virtual Implementation Meeting of May 2021, creating new ECCN 2D352 to control software designed for nucleic acid assemblers and synthesizers (ECCN 2B352.j) that is capable of designing and building functional genetic elements from digital sequence data. The rule also amends ECCN 2E001 to capture technology for the development of 2D352-controlled software. Exports to most non-allied destinations require a BIS licence under CB Column 2 and AT Column 1, and the classification of 2D352 software as a critical technology triggers mandatory CFIUS filing requirements for qualifying foreign investment.
BIS amends the Export Administration Regulations (EAR) Commerce Control List to clarify the scope of ECCN 1C991 (vaccines, immunotoxins, and related medical products containing or derived from controlled biological agents) consistent with release and exclusion notes adopted at the June 2019 Australia Group (AG) Plenary Meeting. The rule adds clarifying language specifying which vaccines and medical products fall inside versus outside the ECCN 1C991 control perimeter, ensuring that routine vaccines produced by standard manufacturing methods are properly excluded. The changes align US controls with the Australia Group Common Control Lists without introducing new country-specific restrictions or license requirements.